Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF)
$ 28.6 0 (0%) Market Cap: 44.77 Bil Enterprise Value: 71.99 Bil PE Ratio: 23.21 PB Ratio: 0.98 GF Score: 78/100

Takeda Pharmaceutical Co Ltd R&D Day - New York Transcript

Nov 14, 2019 / 05:30PM GMT
Release Date Price: $40
Sheelagh Cawley;Knopf
Takeda Pharmaceutical Company Limited - Head, R&D Global Portfolio Strategy

(presentation)

Good afternoon, and welcome. It is my pleasure to welcome you all today to Takeda Pharmaceutical's R&D Day 2019. Along with all of us here in the room in New York, we are joined by a number of people by webcast. I'd like to thank you all for having joined us.

2019 has been a watershed year for Takeda. Today, we will share with you our plans for our near-term growth. We will share with you the confidence that we have in our long-term sustainable growth, and today, we will showcase how we are doing more for our patients worldwide.

I am Sheelagh Cawley-Knopf. I am Head of Global Portfolio Strategy and R&D, and I am your MC and your host for today's event.

Let me take a moment to walk you through today's event. I'd like to ask each of the speakers to stand up as I call your name. We will kick off shortly with welcoming -- with an overview of Takeda -- sorry, with Takeda by our President and CEO, Dr. Christophe Weber. We will then

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot